Faculty Information - SHIMIZU Tomokazu

Books

Published papers

Academic conference presentation

Social activities

Research grants & projects

Education

Rsearch funding number

（Last updated : 2025-06-17 16:00:44）

SHIMIZU Tomokazu
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Associate Professor

■ Books

1.	Chapter contribution	Current situation of ABO-incompatible kidney transplantation in Japan., ABO-incompatible Kidney Transplantation 2016
2.	Chapter contribution	Deoxyspergualin(gusperimus hydrocloride) 2013/04
3.	Chapter contribution	Immunoinsufficiency 2013/04
4.	Chapter contribution	Urologic infection 2013/04

■ Published papers

1.	Other	IP17-15 GENE PROFILE OF OLD DONOR KIDNEY RELATED TO KIDNEY FUNCTION BEFORE AND AFTER KIDNEY TRANSPLANTATION 2025/05
2.	Original article	Comparing surgical outcomes between robot-assisted laparoscopic and open partial nephrectomy for allograft kidney tumors: a retrospective, single-center study. 2025/03
3.	Original article	Outcomes of kidney transplantation in recipients with SARS-cov-2 infection: a 282-case single-center experience in Japan. 2025/02
4.	Original article	Unveiling spatial immune cell profile in kidney allograft rejections using 36-plex immunofluorescence imaging. 2024/12
5.	Case report	Tips for percutaneous nephrolithotomy for transplant kidney stone. 2024/10/13
6.	Original article	Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study. 2024/10/03
7.	Original article	Renal outcome of living kidney donors aged more than 70 years. 2024/09
8.	Original article	Comparative analysis of real-world efficacy and safety of hypoxia-inducible factor prolyl-hydroxylase inhibitors in kidney transplant recipients versus nontransplant individuals: A single-center study. 2024/07
9.	Case report	Treatment of allograft’ ureteral stones with percutaneous laser lithotripsy in a patient post-kidney-transplant: A case report. 2024/07
10.	Original article	Variations of vascular reconstruction in kidney transplantation with multiple renal graft arteries . 2024/06/11
11.	Other	Prediction of 10-yr Renal Graft Survival of Deceased Donors Based on Preoperative Data Using Machine Learning 2024/06
12.	Original article	Safety of docetaxel in a patient with metastatic castration-resistant prostate cancer after kidney transplantation: A case report. 2024/04
13.	Original article	Higher donor age and severe microvascular inflammation are risk factors for chronic rejection after treatment of active antibody-mediated rejection. 2024/02
14.	Original article	Clinical course of candidate renal tansplant recipients diagnosed with prostate cancer during pre-transplant screening test. 2024/01
15.	Original article	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/11
16.	Case report	A case of kidney transplantation for complete C4 deficiency with recurrent IgM-monoclonal gammopathy of renal significance (MGRS) associated nephropathy. 2023/09
17.	Original article	Comparison of three prognostic and predictive scores in 10 patients with COVID-19 pneumonia caused by nosocomial infection. 2023/07
18.	Original article	Case report: suspected hyperacute rejection during living kidney transplantation. 2023/05/01
19.	Original article	Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan academic consortium of kidney transplantation study-II. 2023/05
20.	Original article	A Comparative Study on the Variation in Seropositivity Rates After 2-Dose COVID-19 Vaccination Before or After Transplant: A Single-Center Analysis. 2022/12
21.	Case report	Allogeneic kidney transplantation after COVID-19: A case report. 2022/07
22.	Case report	Case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. 2022/07
23.	Case report	Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. 2022/07
24.	Original article	Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. 2022/03
25.	Original article	Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg. 2022/03
26.	Case report	Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. 2022/01
27.	Case report	A case of novel coronavirus disease after combination therapy with nivolumab and ipilimumab for metastatic renal cell carcinoma. 2021/12/30
28.	Case report	Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. 2021/10
29.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. 2021/06
30.	Review article	Renal allograft urolithiasis after renal transplantaion. 2020/12/10
31.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7-years of follow-up after renal transplantation. 2020/12
32.	Case report	Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review. 2020/11
33.	Original article	Clinicopathologic analyses of chronic vascular rejection after kidney transplantation. 2020/07
34.	Original article	Post-donation satisfaction in kidney transplantation: a survey of living donors in Japan 2019/10/26
35.	Original article	Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study 2019/10/03
36.	Original article	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? 2019/04
37.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
38.	Original article	Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer. 2018/10
39.	Original article	Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation. 2017/06
40.	Original article	Relationship between de novo donor-specific anti-HLA-DQ antibody and chronic antibody-mediated rejection in kidney transplant recipients. 2017/04
41.	Original article	Diabetes mellitus after kidney transplantation in Japanese patients:The Japan Academic Consortium of Kidney Transplantation study. 2017/03
42.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
43.	Original article	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation. 2016/07
44.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
45.	Case report	Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. 2016/07
46.	Case report	Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients 2016/04/01
47.	Original article	Efficacy and feasibility of low-dose rate brachytherapy for prostate cancer in renal transplant recipients. 2016/04/01
48.	Original article	Post-transplant lymphoproliferative disorder in kidney transplant recipients: A single-center experience in Japan. 2016/04
49.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
50.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
51.	Original article	Reliability of tacrolimus determination using Electro-Chemiluminesence Immunoas-say(ECLIA). 2016/03
52.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
53.	Original article	Evaluation of the variability among two reference Flow Cytometry Crossmatch. 2015/10
54.	Case report	A Case of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation Associated With Variant Conversion in the Columbia Classification 2015/07
55.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
56.	Original article	Clinical and pathological analyses of chronic vascular rejection after kidney transplantation. 2015/07
57.	Original article	The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients. 2015/07
58.	Original article	Evaluation of assay methods for tacrolimus concentration on renal transplantation-CLIA, EMIT, and ECLIA- 2015/03
59.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
60.	Original article	Clinical and pathological analyses of transplant glomerulopathy cases. 2014/06
61.	Original article	Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment. 2014/04
62.	Original article	Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center 2013/10
63.	Original article	Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome 2013/09
64.	Original article	Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus 2013/07
65.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
66.	Original article	Acute vascular rejection after renal transplantation and isolated v-lesion 2012/07
67.	Original article	Clinical and pathological analysis of transplant glomerulopathy cases 2012/07
68.	Original article	Immunohistological study of a pediatric patient with plasma cell-rich acute rejection 2012/07
69.	Original article	Improvement of Urinary Dysfunction After Kidney Transplantation by Administration of the Antimuscarinic Agent-Prospective Randomized Controlled Study 2012/03
70.	Original article	Clinicopathologic Analysis of Acute Vascular Rejection Cases After Renal Transplantation 2012/02
71.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
72.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
73.	Original article	BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report 2011
74.	Original article	Mild rhabdomyolysis after renal transplantation 2011
75.	Original article	Bladder function of end-stage renal disease patients 2010/09
76.	Original article	Clinicopathological analysis of acute vascular rejection cases after renal transplantation. 2010/07
77.	Original article	Changes in anti-HLA antibody titers more than 1 year after desensitization therapy with rituximab in living-donor kidney transplantation. 2010
78.	Original article	Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation. 2010
79.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
80.	Original article	Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. 2010
81.	Original article	Risk factors for deterioration of renal function after donor nephrectomy 2010
82.	Original article	Clinicopathological analysis of transplant glomerulopathy cases 2009/08
83.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
84.	Original article	Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation 2009
85.	Original article	A case of plasma cell-rich acute rejection 18 months after kidney transplantation successfully treated with steroid pulse therapy 2008/07
86.	Original article	Persistent subclinical rejection associated with nodular B-cell infiltrates in a renal transplant recipient 2008/07
87.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
88.	Original article	Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation 2008/06
89.	Original article	Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation 2008/01
90.	Original article	Clinical and Histological Analysis of Chronic Tacrolimus Nephrotoxicity in Renal Allografts 2008
91.	Original article	Evaluation of Immunosuppressive Regimens in ABO-Incompatible Living Kidney Transplantation-Single Center Analysis 2007/04
Display 5 items
Display all(91)

■ Academic conference presentation

1.	Gene profile of old donor kidney related to kidney function before and after kidney transplantation. （Poster notice，General） 2025/04/28
2.	Validity of automatic diagnosis system for transplant kidney pathology : Comparison with diagnosis by pathologist. （Speech，General） 2024/11/16
3.	Optimization of a model for predicting renal function after living kidney transplantation using CT volumetry. （Speech，Panelist at Symposium/Workshop (Other)） 2024/11/15
4.	Predictive value of HLAMatchmaker and PIRCHE-II scores for de novo donor-specific antibody formation after kidney transplantation-A Japanese single-center study. （Poster notice，General） 2024/11/14
5.	Relationship between Parenchymal Stiffness and Renal Fibrosis in Kidney Transplant Recipients （Poster notice，General） 2024/10/24
6.	Clinicopathological evaluation of living-related kidney transplantation from older adult donors: A focus on zero-time biopsy findings. （Poster notice，General） 2024/06/04
7.	Discordance between banff automation system and pathologists in diagnosing chronic antibody-mediated rejection in clinical practice. （Poster notice，General） 2024/06/04
8.	Spatial transcriptomic analysis uncovers gene expression profiles in peritubular capillaritis in antibody-mediated rejection. （Speech，General） 2024/06/03
9.	Predicting short-term outcomes of living kidney donor by machine learning. （Poster notice，General） 2024/06/01
10.	Prediction of 10-yr renal graft survival of deceased donors based on preoperative data using machine learning. （Poster notice，General） 2024/06/01
11.	The association between parenchymal stiffness and renal allograft fibrosis in kidney transplant recipients. （Poster notice，General） 2024/06/01
12.	Clinical course of candidate renal transplant recipients diagnosed with prostate cancer during pre-transplant screening test. （Poster notice，General） 2024/04/27
13.	Prediction of 10-yr renal graft survival of deceased donors based on preoperative data using machine learning. （Poster notice） 2024/04/25
14.	The potential of donor-derived-cell-free DNA for rejection diagnosis in Japanese cohort. （Poster notice） 2024/04/25
15.	Validity of automatic diagnosis system for transplant kidney pathology : Comparison with diagnosis by pathologist. （Poster notice） 2024/04/25
16.	Assessing long-term complications of kidney transplantation without intraoperative ureteral dj stent: A single-center experience. （Poster notice，General） 2023/06/06
17.	Elderly living kidney transplant donors and their renal prognosis. （Poster notice，General） 2023/06/06
18.	Safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor in kidney transplant patients with post-transplant anemia. （Poster notice，General） 2023/06/05
19.	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. （Poster notice，General） 2023/06/03
20.	Computational analysis of multiplex immunofluorescence imaging identifies endothelial cell-macrophage interaction as a potential novel spatial biomarker in antibody mediated kidney rejection. （Speech，General） 2023/06/03
21.	10-years long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation. （Speech，General） 2023/04/20
22.	CODEX multiplex immune-staining Identifies novel spatial indexes for antibody-mediated rejection diagnosis. （Poster notice） 2023/04/20
23.	A case of living kidney transplantation suspected of hyper-acute rejection during kidney transplant surgery. （Speech，General） 2022/11/26
24.	Clinicopathological analyses of chronic vascular rejection after kidney transplantation. （Speech，General） 2022/11/26
25.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. （Speech，General） 2022/11/26
26.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. （Poster notice，General） 2022/10/24
27.	Desensitization protocol to prevent severe oliguric antibody-mediated rejection. （Poster notice，General） 2022/06/05
28.	The relevance of naturally occurring non-HLA antibody to antibody-mediated rejection in patients without anti-HLA antibodies. （Poster notice，General） 2021/08/29
29.	Relationship between tacrolimus blood levels and covid-19 pandemic in kidney transplant recipients. （Poster notice，General） 2021/06/04
30.	Diagnosis and treatment for urolithiasis after kidney transplantation （Speech，General） 2020/12/24
31.	Pathological investigation about renal transplant lost allografts. （Speech，General） 2020/12/23
32.	Investigation of robotic assisted radical prostatectomy in our hospital. （Poster notice，General） 2020/12/22
33.	Quantitative analysis of humoral immunity by flow-cytometric crossmatch using molecules of equivalent soluble fluorochromosome (FCXM-MESF). （Poster notice，General） 2020/05/30
34.	Clinical and pathological analysis of chronic vascular rejection after kidney transplantation. （Poster notice，General） 2019/09/24
35.	Correlation between the HLA antibody screening test and the specificity identification test. （Poster notice，General） 2019/09/15
36.	Pregnancy outcomes in kidney transplant recipients. （Poster notice，General） 2019/06/03
37.	Return to work after sick leave in kidney transplant recipients: A 365day cohort of the Japan academic consortium of kidney transplantation (JACK) study. （Poster notice，General） 2019/06/03
38.	Evaluation of Urine BK Virus-PCR Measurement as a Screening Tool for Kidney Transplant Recipients （Speech，General） 2018/11/24
39.	The Evaluation of Urine BK Virus PCR Measurement for Kidney Transplantation Recipients （Speech，General） 2018/10/05
40.	Clinical and pathological analysis of chronic vascular rejection after renal transplantation. （Speech，General） 2018/07/21
41.	Influence of trough level in tacrolimus on the appearance rate of de novo donor specific antibody (dnDSA) under low dose-based tacrolimus protocol during 7 years follow-up after renal transplantation. （Poster notice，General） 2018/06/04
42.	Recurrence of immunoglobulin a nephropathy in related donor kidney transplant recipients. （Speech，General） 2018/06/03
43.	Monoclonal IgG Deposits on Tubular Basement Membrane in Renal Allograft: Is This Significant for Chronic Allograft Injury? （Poster notice，General） 2017/11/04
44.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. （Poster notice，General） 2017/05/02
45.	Renal transplantation to the extraperitoneal cavity in children weighing less than 15 kg can be performed safely. （Poster notice，General） 2017/05/02
46.	A comparative study of patient and graft qualities between abo- compatible and- incompatible recipients more than ten years after kidney transplantation. （Poster notice，General） 2017/05/01
47.	Outcome of living-donor kidney transplantation in cross-match-positive recipients at a single center. （Poster notice，General） 2017/04/29
48.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. （Speech） 2016/10/29
49.	Post-transplant diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. （Speech，General） 2016/08/23
50.	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy (IF/TA) cases after kidney transplantation. （Poster notice，General） 2016/08/20
51.	Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial. （Poster notice，General） 2016/08/20
52.	Efficacy and feasibility of radiotherapy for localized prostate cancer in renal transplant recipients: a single-center experience. （Poster notice，General） 2016/08/20
53.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary? （Poster notice，General） 2016/08/20
54.	Preemptive kidney transplantation in Japanese patients: A propensity score-matched study. （Poster notice，General） 2016/08/20
55.	Relationship between de novo donor-specific anti-HLA-DQ antibody and chronic antibody-mediated rejection in kidney transplant recipients. （Poster notice，General） 2016/08/20
56.	Relationship between dialysis duration and prevalence of cardiovascular diseases in kidney transplantation recipients. （Poster notice，General） 2016/08/20
57.	Clinicopathological analysis of acute vascular rejection cases after kidney transplantaion. （Speech，General） 2016/07/16
58.	The cases of two recipients of kidneys from an identical deceased donor who had diabetic nephropathy. （Poster notice，General） 2016/07/16
59.	Glomerular capillary C4d staining without evidence of rejection is associated with worse graft function in ABO-incompatible Kidney Transplantation. （Poster notice，General） 2016/06/13
60.	Pharmakokinetics of prolonged-release formulation of tacrolimus:Comparison of AUC0-24 and concentration at 10 time points. （Poster notice，General） 2016/06/13
61.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation - Is prophylactic treatment necessary? （Poster notice，General） 2016/06/13
62.	Relationship between dialisys duration and prevalence of cardiovascular diseases in kidney transplantation recipients. （Poster notice，General） 2016/06/13
63.	The significance of microvascular inflammation in antibody-mediated rejection in ABO-incompatible kidney transplantation. （Poster notice，General） 2016/06/13
64.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. （Poster notice，General） 2016/06/11
65.	Association between pretransplant body mass index and outcomes in patients undergoing living kidney transplantation: A consideration of gender differences. （Poster notice，General） 2016/06/11
66.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation - Prospective trial of once-daily vs.twice-daily Tac - 5 years second report. （Poster notice，General） 2016/06/11
67.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation （Poster notice，General） 2015/11/07
68.	Efficacy and feasibility of intensity-modulated radiation therapy for prostate cancer in renal-transplant recipients. （Poster notice，General） 2015/08/26
69.	Efficacy and feasibility of low-dose brachytherapy for prostate cancer in renal-transplant recipients. （Poster notice，General） 2015/08/26
70.	Robot-assisted radical prostatectomy in renal transplant recipients: the first report in asian patient. （Poster notice，General） 2015/08/26
71.	Incidence of hepatitis B virus reactivation in kidney transplant patients who received rituximab administration. （Poster notice，General） 2015/05/05
72.	Long-term excellent results of ABO-incompatible kidney transplantations at multicenter Japanese case series. （Speech，General） 2015/05/04
73.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. （Poster notice，General） 2015/05/03
74.	Outcome of kidney transplantation from obese living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
75.	Outcome of kidney transplantation from older living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
76.	Outcome of kidney transplantation using right versus three left renal arteries after retroperitoneoscopic donor nephrectomy:A single-center experience of 764 cases. （Poster notice，General） 2015/05/03
77.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. （Poster notice，General） 2015/05/02
78.	Efficacy of rituximab, an anti-CD20 antibody for preventing hemolysis due to passenger leucocyte syndrome (PLS). （Poster notice，General） 2014/07/30
79.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation -prospective trial of once-daily vs. twice-daily tac -3 years second report. （Poster notice，General） 2014/07/29
80.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. （Speech，General） 2014/07/29
81.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. （Poster notice，General） 2014/07/29
82.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. （Poster notice，General） 2014/07/29
83.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. （Poster notice，General） 2014/07/29
84.	Risk factors of preterm delivery at less than 35 weeks in patients with kidney transplantation. （Poster notice，General） 2014/07/29
85.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. （Speech，General） 2014/07/29
86.	Assessment of long-term outcomes after kidney retransplantation. （Poster notice，General） 2014/07/28
87.	Late-onset neutropenia (LON) After low-dose rituximab treatment in living related kidney transplantation.-Single-center study- （Speech，General） 2014/07/28
88.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. （Poster notice，General） 2014/07/28
89.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. （Poster notice，General） 2014/07/28
90.	Clinical and pathological analysis of transplant glomerulopathy cases. （Poster notice，General） 2014/07/27
91.	Influences of the CD20 Ab rituximab on the renal transplant recipients and renal grafts 5 to 8 years after immunologically high-risk renal transplantation. （Poster notice，General） 2014/07/27
92.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. （Poster notice，General） 2014/07/27
93.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. （Poster notice，General） 2014/07/27
94.	RESUL OF TRANSURETHRAL URETEROLITHOTRIPSY(TUL) AND CLINICAL CHARACTERISTICS OF ACUTE PYELONEPHRITIS FOLLWING TUL （Speech，General） 2013/10/25
95.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution （Poster notice，General） 2013/09/04
96.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity （Speech，General） 2013/09/04
97.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment （Poster notice，General） 2013/05/21
98.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for over 20 Years （Speech，General） 2013/05/21
99.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression （Poster notice，General） 2013/05/21
100.	Evaluation of Low-Dose Rituximab Treatment;the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients （Poster notice，General） 2013/05/20
101.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity （Poster notice，General） 2013/05/19
102.	Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a BCell-Depleting Treatment （Poster notice，General） 2013/05/19
103.	Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients With or Without Rituximab Treatment （Speech，General） 2013/05/19
104.	Microvascular Inflammation as a Core Element of Diagnostic Criteria of Antibody-Mediated Rejection(ABMR): C4d Positivity Is Not Reliable Element in Diagnosis of ABMR （Speech，General） 2013/05/19
105.	MFI Detected by Luminex in Patients with Chronic Active Antibody Mediated Rejection （Poster notice，General） 2012/10/20
106.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries （Speech，General） 2012/10/20
107.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases （Poster notice，General） 2012/07/19
108.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation （Poster notice，General） 2012/07/19
109.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for Over 20 Years （Speech，General） 2012/07/19
110.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome(FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation （Poster notice，General） 2012/07/19
111.	Can We Predict the Occurrence of Medullary Ray Injury from the Investigation of Bladder Function before Kidney Transplantation? （Speech，General） 2012/06/05
112.	The Signifi cance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection （Speech，General） 2012/06/05
113.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases （Speech，General） 2012/06/04
114.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation （Speech，General） 2012/06/04
115.	The Impact of B-Cell Depleting Treatment on Marked Reduction of Chronic Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation （Speech，General） 2012/06/04
116.	An Open Label, Prospecive Randomized Controlled Study Comparing Tacrolimus Once-Daily and Twice-Daily in De Novo Kidney Transplatation: Pharmacokinetics and Pathological Analysis by Protocol Biopsy （Speech，General） 2012/06/03
117.	Long-Term Follow-Up of Kidney Transplant Recipient with Calcineurin Inhibitor-Associated Nephrotoxicity （Speech，General） 2012/06/03
118.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years （Speech，General） 2012/06/02
119.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy （Speech，General） 2012/04/23
120.	Prophylactic therapy for antibody-mediated rejection during introductory period in kidney transplantation(Symposium7 Antibody-mediated rejection in kidney transplantation) （Speech，Panelist at Symposium/Workshop (Other)） 2012/02/03
121.	Chimerism of blood type antigens on the vessel endothelium in patients with antibody-mediated rejection （Speech，General） 2011/09/04
122.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation （Speech，General） 2011/06
123.	Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation （Speech，General） 2011/06
124.	Impact and Implication of Renal Artery Number on Outcomes of Renal Donors and Recipients in Retroperitoneoscopic Live Donor Nephrectomy-Experience of 500 Cases at a Single Center （Poster notice，General） 2011/05/03
125.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy:Experience of 479 Cases at a Single Center （Poster notice，General） 2011/05/03
126.	Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 500 Cases at a Single Center （Poster notice，General） 2011/05/03
127.	Excellent Outcomes of Rituximab Administration Plus Plasmapheresis as Prophylactic Treatment Prior to Kidney Transplantation in Patients with Focal Segmental Glomerulosclerosis （Poster notice，General） 2011/05/02
128.	Decrease of Blood-Type Antigenicity over the Long-Term after ABO-Incompatible Kidney Transplantation （Poster notice，General） 2011/05/01
129.	Significance of Qualitative and Quantitative Evaluations of Anti-HLA Antibodies in Kidney Transplantation （Poster notice，General） 2011/05/01
130.	Significant Reduction in Chronic Antibody-Mediated Rejection after B-Cell Depleting Treatment in ABO-Incompatible Living Kidney Transplantation （Speech，General） 2011/05/01
131.	Rituximab Therapy Reduces Peripheral B Cells for a Long Time in ABO Incompatible Kidney Transplantation; a Single Center Experience （Poster notice，General） 2011/04/30
132.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation （Speech，General） 2010/05
133.	Excellent long-term outcomes of donor-specific anti-HLA antibody(DSA) positive renal transplant recipients and significant elimination of posttransplant DSA by combination treatment of basiliximab and rituxaimab inductoin （Speech，General） 2010/05
134.	New-onset diabetes after transplantaion in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT （Speech，General） 2010/05
135.	Outcome of kidney transplantation from living older donors: histologiucal evaluation using zero-time biopsy （Speech，General） 2010/05
136.	Outcome of retroperitoneoscopic living donor nephrectomy in obese donors （Speech，General） 2010/05
137.	Surgical complications of pediatric kidney transplantation:A single center experience （Speech，General） 2010/05
138.	The Low dose rituximab preconditioning in ABO-incompatible kidney transplantation: A 3-year follow up （Speech，General） 2010/05
Display 5 items
Display all(138)

■ Social activities

2017/03

1st East Asia Transplant Expert Meeting Discussion Banff classification Moderator

■ Research grants & projects

2022/04～2025/03

Assessing the risk of renal allograft' rejection by immunocytospatial analysis (Key Word : )

■ Education

1986/04～1992/03

Department of medicine, Faculty of Medicine, Shimane Medical University, Graduated, Medical doctor

■ Rsearch funding number

60307593